In this regard, obtaining tissue-related biomarkers is often challenging in advanced disease and expression of such biomarkers (e.g., cancer programmed cell death-ligand 1, PD-L1) display variability in time and space within the tumor, limiting their predictive value [4]. The gene discussed is CD274; the disease is neoplasm.